## **Core Concept**
Hepatitis C infection is a viral infection that causes liver inflammation, sometimes leading to severe liver damage. The treatment for hepatitis C involves antiviral medications, and the choice of treatment depends on the genotype of the virus, the extent of liver damage, and the patient's age and overall health.

## **Why the Correct Answer is Right**
The correct answer, , involves the use of Sofosbuvir and Daclatasvir. This combination is a preferred treatment option for chronic hepatitis C infection in children and adults due to its high efficacy, safety profile, and relatively short treatment duration. Sofosbuvir is a nucleotide polymerase inhibitor, and Daclatasvir is a NS5A inhibitor. Together, they work synergistically to inhibit the replication of the hepatitis C virus.

## **Why Each Wrong Option is Incorrect**
* **Option A:** - This option is incorrect because Ribavirin is sometimes used in combination with other medications for treating hepatitis C, but it is not the first choice for children due to potential side effects and the availability of more effective and safer regimens.
* **Option B:** - This option is incorrect as Interferon-based therapies were once used but are no longer the preferred treatment due to their lower efficacy and higher side effect profile compared to direct-acting antivirals like Sofosbuvir and Daclatasvir.
* **Option C:** - This option might seem plausible but is not the best choice for an 11-year-old child with hepatitis C.

## **Clinical Pearl / High-Yield Fact**
A key point to remember is that the treatment of hepatitis C has evolved significantly with the introduction of direct-acting antivirals (DAAs), which offer high cure rates and are generally well-tolerated. For pediatric patients, it's crucial to select treatments that are not only effective but also have a favorable safety profile.

## **Correct Answer:** . Sofosbuvir + Daclatasvir